The semaglutide group had a 0.33 percentage point reduction in HbA1c ( P = .034), a 0.37 mmol/L decrease in total cholesterol ( P = .04) and a 0.29 mmol/L decline in LDL cholesterol ( P = .05) from baseline to 1 year
Studies should also distinguish between surrogate outcomes and clinical outcomes
Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]
4 In addition, genetic and epigenetic changes to DNA can affect the ability of sperm to fertilize an egg and create a viable embryo
Also, assess weight changes and symptoms related to GI side effects, which are common in the first few months
Most healthcare providers advise against purchasing medications from international sources due to these concerns